Lymphoscintigraphy for Sentinel Node Mapping in Head and Neck Cancer

Area of Science:

• Oncology
• Nuclear Medicine
• Surgical Oncology

Background:

• Head and neck cancers encompass cutaneous malignancies and upper aerodigestive tract neoplasms.
• Accurate staging and treatment planning are crucial for improving patient outcomes.
• Sentinel lymph node (SLN) mapping is an evolving technique for assessing regional lymph node metastasis.

Purpose of the Study:

• To review and analyze the efficacy of sentinel node mapping in head and neck cancers.
• To categorize findings based on cancer type: cutaneous malignancies and upper aerodigestive tract neoplasms.
• To evaluate detection rates, false-negative rates, and overall accuracy of SLN identification.

Main Methods:

• Comprehensive literature review focusing on lymphoscintigraphy for SLN detection.
• Analysis of detection rates, true-positive rates, false-negative rates, and accuracy.
• Categorization of studies based on tumor location (cutaneous vs. upper aerodigestive tract).

Main Results:

• Cutaneous head and neck neoplasms demonstrate detection rates exceeding 90%, with melanoma posing challenges due to false negatives.
• For oral cavity and oropharynx cancers, SLN mapping by lymphoscintigraphy can help avoid unnecessary neck dissections or irradiation.
• Data for laryngeal and hypopharyngeal cancers are limited, requiring further multicenter validation of lymphoscintigraphy performance.

Conclusions:

• Sentinel node mapping is a valuable tool in head and neck oncology, particularly for cutaneous and certain aerodigestive tract cancers.
• Ongoing research into new tracers and techniques is necessary to address limitations like false-negative rates, especially in melanoma.
• Prospective multicenter trials are essential to confirm the impact of SLN mapping on patient outcomes and refine its application across diverse head and neck cancer types.